You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星國際(00656.HK):累計耗資5.17億港元增持復宏漢霖非上市股份

格隆匯4月21日丨復星國際(00656.HK)公佈,於2025年4月17日,復星醫藥產業(公司透過復星醫藥持有之附屬公司,作爲買方)與HenLink(作爲賣方)簽訂本次股份轉讓協議,據此,復星醫藥產業同意購買,HenLink同意出售14,940,694股復宏漢霖非上市股份,每股代價爲港幣24.6元。總代價爲港幣367,541,072.40元,將通過現金支付。

於2025年4月11日,復星醫藥產業(作爲買方)與無錫通善、上海善梧(作爲賣方)簽訂股份轉讓協議,據此,復星醫藥產業同意購買,無錫通善及上海善梧分別同意出售4,666,667股及45,752股復宏漢霖非上市股份,每股代價爲港幣24.6元。總代價合共爲港幣115,925,507.40元,以現金方式支付。

於2025年4月15日,復星醫藥產業(作爲買方)與舟山果運(作爲賣方)簽訂股份轉讓協議,據此,復星醫藥產業同意購買,舟山果運同意出售1,381,200股復宏漢霖非上市股份,每股代價爲港幣24.6元。總代價爲港幣33,977,520元,以現金方式支付。

於該等增持前及該等增持完成後,公司透過復星醫藥分別持有復宏漢霖已發行股份總數之59.56%及63.43%(假設於本公告日期至該等增持完成之日復宏漢霖已發行股份總數並無變動)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account